Yehonatan Sharabi Selected Research

Orthostatic Hypotension (Postural Hypotension)

10/2020	Cardiac sympathetic innervation and vesicular storage in pure autonomic failure.
1/2019	The heart of PD: Lewy body diseases as neurocardiologic disorders.
1/2019	Alpha-Synuclein Deposition Within Sympathetic Noradrenergic Neurons Is Associated With Myocardial Noradrenergic Deficiency in Neurogenic Orthostatic Hypotension.
12/2018	The Effect of Head and Neck Radiotherapy on Blood Pressure and Orthostatic Hypotension in Patients With Head and Neck Tumors.
1/2017	Pure autonomic failure without synucleinopathy.
1/2017	Autoimmunity-associated autonomic failure with sympathetic denervation.
11/2015	Survival in synucleinopathies: A prospective cohort study.
2/2015	Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
2/2012	Orthostatic hypotension is associated with nocturnal change in systolic blood pressure.
11/2011	Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yehonatan Sharabi Research Topics

Disease

35	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2003
19	Orthostatic Hypotension (Postural Hypotension) 10/2020 - 08/2003
17	Hypertension (High Blood Pressure) 10/2021 - 07/2003
14	Multiple System Atrophy 01/2021 - 08/2003
12	Pure Autonomic Failure 01/2021 - 08/2003
9	Synucleinopathies 01/2022 - 08/2011
8	Parkinsonian Disorders (Parkinsonism) 01/2017 - 04/2008
7	Pheochromocytoma 10/2020 - 10/2005
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2008
5	Body Weight (Weight, Body) 12/2018 - 01/2008
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 05/2005
4	Neoplasms (Cancer) 12/2018 - 07/2003
3	Movement Disorders (Movement Disorder) 01/2020 - 11/2011
3	Dementia (Dementias) 01/2019 - 11/2011
3	Lewy Body Disease (Lewy Body Dementia) 01/2017 - 08/2011
2	Paraganglioma (Paragangliomas) 10/2020 - 10/2005
2	Anosmia 01/2019 - 11/2011
2	REM Sleep Behavior Disorder 01/2019 - 11/2011
2	dopamine beta hydroxylase deficiency 01/2019 - 06/2012
2	Essential Hypertension 07/2013 - 08/2003
2	Weight Loss (Weight Reduction) 11/2012 - 05/2004
2	Dizziness (Lightheadedness) 11/2011 - 07/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2011 - 05/2005
2	Hyperinsulinism (Hyperinsulinemia) 09/2008 - 01/2008
2	Insulin Resistance 09/2008 - 05/2005
2	Hypertriglyceridemia 09/2008 - 01/2008
2	Obesity 05/2005 - 05/2004
1	Fatty Liver 04/2022
1	Rare Diseases (Rare Disease) 10/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2018
1	Disease Progression 11/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2016
1	Polycythemia (Erythrocytosis) 06/2015
1	Fever (Fevers) 06/2015
1	Familial Mediterranean Fever (Periodic Disease) 06/2015
1	Primary Myelofibrosis (Myelosclerosis) 06/2015
1	Dyslipidemias (Dyslipidemia) 03/2013
1	Hyponatremia 08/2012
1	Wounds and Injuries (Trauma) 11/2011

Drug/Important Bio-Agent (IBA)

19	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 04/2008
14	CatecholaminesIBA 01/2022 - 07/2003
10	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 08/2003
10	alpha-SynucleinIBA 01/2021 - 02/2012
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
9	hydroxide ionIBA 01/2019 - 08/2003
6	3,4-dihydroxyphenylacetaldehydeIBA 11/2017 - 12/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
5	AdiponectinIBA 07/2013 - 05/2005
4	FructoseIBA 04/2022 - 02/2007
4	SynucleinsIBA 01/2020 - 08/2011
4	Antihypertensive Agents (Antihypertensives)IBA 04/2014 - 05/2004
4	Triglycerides (Triacylglycerol)IBA 07/2013 - 01/2008
3	Aldehyde DehydrogenaseIBA 01/2022 - 04/2015
3	RotenoneIBA 01/2022 - 04/2015
3	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020 - 09/2008
3	CatecholsIBA 01/2019 - 02/2006
3	Monoamine Oxidase (MAO)IBA 11/2017 - 02/2016
3	TyramineIBA 02/2016 - 09/2008
3	Insulin (Novolin)FDA Link 03/2013 - 01/2008
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2022 - 04/2015
2	SaltsIBA 10/2021 - 01/2010
2	MelatoninIBA 10/2021 - 10/2006
2	3,4-Dihydroxyphenylacetic AcidIBA 01/2018 - 10/2016
2	Selegiline (E250)FDA LinkGeneric 11/2017 - 09/2016
2	Dihydroxyphenylalanine (Dopa)IBA 09/2015 - 02/2012
2	Mineralocorticoid Receptor AntagonistsIBA 12/2014 - 07/2006
2	Spironolactone (Aldactone)FDA LinkGeneric 12/2014 - 07/2006
2	Glucagon (Glukagon)FDA Link 01/2010 - 09/2008
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2008 - 09/2008
1	LipidsIBA 04/2022
1	NeurotoxinsIBA 08/2021
1	Pharmaceutical PreparationsIBA 08/2021
1	Oxidopamine (6 Hydroxydopamine)IBA 08/2021
1	NormetanephrineIBA 10/2020
1	quinone (benzoquinone)IBA 01/2018
1	rasagiline (Azilect)FDA Link 09/2016
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 09/2016
1	Clorgyline (Clorgiline)IBA 09/2016
1	PyrinIBA 06/2015
1	Colchicine FDA LinkGeneric 06/2015
1	DNA (Deoxyribonucleic Acid)IBA 06/2015
1	Janus Kinase 2IBA 06/2015
1	AldehydesIBA 03/2015
1	PotassiumIBA 12/2014
1	Neprilysin (Neutral Endopeptidase)IBA 04/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2014
1	Enalapril FDA LinkGeneric 04/2014
1	candoxatrilIBA 04/2014
1	Atrial Natriuretic Factor (ANF)IBA 04/2014
1	allicinIBA 03/2013
1	Blood Glucose (Blood Sugar)IBA 03/2013
1	ThiazidesIBA 08/2012
1	AcidsIBA 06/2012

Therapy/Procedure

10	Sympathectomy (Sympathectomies) 01/2019 - 12/2005
8	Denervation 01/2019 - 09/2008
5	Therapeutics 12/2018 - 05/2004
2	Radiotherapy 12/2018 - 07/2003
2	Drug Therapy (Chemotherapy) 08/2006 - 07/2003
1	Lasers (Laser) 06/2015
1	Bariatric Surgery 11/2012